Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy
Phase of Trial: Phase IV
Latest Information Update: 22 Apr 2019
Price : $35 *
At a glance
- Drugs Ciclosporin (Primary) ; Carmellose
- Indications Dry eyes
- Focus Therapeutic Use
- Acronyms IMPACT
- Sponsors Allergan
- 16 Mar 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 30 Oct 2014 Planned End Date changed from 1 Mar 2015 to 1 Oct 2014 as reported by ClinicalTrials.gov.
- 30 Oct 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.